long term side effects of glp-1 for weight loss long-term cancer Overdose risks increase as demand injectable weight-loss drugs on the rise, research finds Is GLP-1 the Same as
Description
The Mental Aspect Its not just about eating
The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms. An estimated 1.6 million UK adults used GLP-1s such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) to lose weight between early 2024 and early 2025, with an additional 3.3 million interested in using weight loss drugs during 2026
NPJ Prim Care Respiratory Med
Eligibility still depends on medical review rather than BMI alone
Some notice nothing at all
